Stock ORCHPHARMA ORCHID PHARMA LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Orchid Pharma Limited

Equities

ORCHPHARMA

INE191A01027

Market Closed - NSE India S.E.
Other stock markets
 07:43:55 2024-07-12 am EDT 		5-day change 1st Jan Change
1,130 INR -1.97% Intraday chart for Orchid Pharma Limited -1.21% +58.56%
Jun. 28 Orchid Pharma Partners with Cipla to Launch Antibiotic Cefepime- Enmetazobactam in India CI
Jun. 06 Orchid Pharma Gets Indian Regulator's Nod for Enmetazobactam MT

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Orchid Pharma Partners with Cipla to Launch Antibiotic Cefepime- Enmetazobactam in India
CI
Orchid Pharma Gets Indian Regulator's Nod for Enmetazobactam
MT
Orchid Pharma Receives DCGI Approval for Its First Invented and Made-In-India Antibiotic Drug Combination of Cefepime and Enmetazobactam
CI
Orchid Pharma Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024
CI
Orchid Pharma Receives United States Food and Drug Administration Approval for Its Novel Invention
CI
Orchid Pharma Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
CI
European Medicines Agency Grants Approval for Orchid Pharma's 'Exblifep'
CI
Orchid Pharma Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
CI
Orchid Pharma Ties Up with GARDP to Manufacture Antibiotic for Certain Gram-Negative Infections
MT
Orchid Pharma Limited Enters into Manufacturing Sub License Agreement with Global Antibiotic Research & Development Partnership
CI
Orchid Pharma Limited Reports Earnings Results for the First Quarter Ended June 30, 2023
CI
Orchid Pharma Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023
CI
Orchid Pharma Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022
CI
Orchid Pharma Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022
CI
Reverse Split: 1 of 219.298203
FA
Ex-dividend day for final dividend
FA
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ORCHPHARMA Stock
  4. News Orchid Pharma Limited
  5. Highlights